240 related articles for article (PubMed ID: 10755519)
1. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
Schuurman HJ; Ringers J; Schuler W; Slingerland W; Jonker M
Transplantation; 2000 Mar; 69(5):737-42. PubMed ID: 10755519
[TBL] [Abstract][Full Text] [Related]
2. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
Hausen B; Ikonen T; Briffa N; Berry GJ; Christians U; Robbins RC; Hook L; Serkova N; Benet LZ; Schuler W; Morris RE
Transplantation; 2000 Jan; 69(1):76-86. PubMed ID: 10653384
[TBL] [Abstract][Full Text] [Related]
3. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
[TBL] [Abstract][Full Text] [Related]
4. Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.
Hausen B; Boeke K; Berry GJ; Segarra IT; Christians U; Morris RE
J Heart Lung Transplant; 1999 Feb; 18(2):150-9. PubMed ID: 10194039
[TBL] [Abstract][Full Text] [Related]
5. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: interaction with cyclosporine.
Serkova N; Hausen B; Berry GJ; Jacobsen W; Benet LZ; Morris RE; Christians U
J Pharmacol Exp Ther; 2000 Jul; 294(1):323-32. PubMed ID: 10871329
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Oct; 9(1):43-9. PubMed ID: 11680571
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD.
Hausen B; Boeke K; Berry GJ; Christians U; Schüler W; Morris RE
Ann Thorac Surg; 2000 Mar; 69(3):904-9. PubMed ID: 10750781
[TBL] [Abstract][Full Text] [Related]
9. SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.
Schuurman HJ; Cottens S; Fuchs S; Joergensen J; Meerloo T; Sedrani R; Tanner M; Zenke G; Schuler W
Transplantation; 1997 Jul; 64(1):32-5. PubMed ID: 9233697
[TBL] [Abstract][Full Text] [Related]
10. Early clinical experience with a novel rapamycin derivative.
Nashan B
Ther Drug Monit; 2002 Feb; 24(1):53-8. PubMed ID: 11805723
[TBL] [Abstract][Full Text] [Related]
11. The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation.
Schuurman HJ; Schuler W; Ringers J; Jonker M
Transplant Proc; 1998 Aug; 30(5):2198-9. PubMed ID: 9723439
[No Abstract] [Full Text] [Related]
12. Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.
Hausen B; Boeke K; Berry GJ; Segarra I; Benet LZ; Christians U; Morris RE
Transplantation; 1999 Apr; 67(7):956-62. PubMed ID: 10221478
[TBL] [Abstract][Full Text] [Related]
13. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.
Schuler W; Sedrani R; Cottens S; Häberlin B; Schulz M; Schuurman HJ; Zenke G; Zerwes HG; Schreier MH
Transplantation; 1997 Jul; 64(1):36-42. PubMed ID: 9233698
[TBL] [Abstract][Full Text] [Related]
14. SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts.
Viklický O; Zou H; Müller V; Lacha J; Szabó A; Heemann U
Transplantation; 2000 Feb; 69(4):497-502. PubMed ID: 10708101
[TBL] [Abstract][Full Text] [Related]
15. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
[TBL] [Abstract][Full Text] [Related]
16. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
Quesniaux VF; Menninger K; Kunkler A; Vedrine C; Bernhard M; Hedinger R; Kraus G; Schuurman HJ
Transpl Immunol; 2000 Nov; 8(3):177-87. PubMed ID: 11147698
[TBL] [Abstract][Full Text] [Related]
17. RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection.
Kahan BD; Kaplan B; Lorber MI; Winkler M; Cambon N; Boger RS
Transplantation; 2001 May; 71(10):1400-6. PubMed ID: 11391226
[TBL] [Abstract][Full Text] [Related]
18. Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients.
Neumayer HH; Paradis K; Korn A; Jean C; Fritsche L; Budde K; Winkler M; Kliem V; Pichlmayr R; Hauser IA; Burkhardt K; Lison AE; Barndt I; Appel-Dingemanse S
Br J Clin Pharmacol; 1999 Nov; 48(5):694-703. PubMed ID: 10594471
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of cyclosporine A and SDZ RAD on neointima formation of carotid allografts in apolipoprotein E-deficient mice.
Matsumoto Y; Hof A; Baumlin Y; Hof RP
Transplantation; 2003 Oct; 76(8):1166-70. PubMed ID: 14578747
[TBL] [Abstract][Full Text] [Related]
20. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
